48 EUR
0.6
1.23%
Last update Dec 16, 11:09 AM CET
Market closed
Day range
46.80000
48
Previous close
48.60000
Open
46.80000
Access this stock data via API
Subscribe
Crispr Therapeutics AG
48.00
0.60
1.23%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 29.8M
Cost of revenue 48.7M 38.5M 49.0M 0
Gross profit -48.7M -38.5M -49.0M 29.8M
Operating expense
Research & development 50.2M 141.6M 61.8M 70.0M
Selling general and admin 14.4M 16.1M 16.4M 15.4M
Other operating expenses -757.7K -760.2K -737.2K -588.9K
Operating income -112.5M -195.4M -126.5M -55.0M
Non operating interest income
Income
Expense
Other income expense 22.4M 18.8M 11.5M 23.8M
Pretax income -90.2M -176.6M -115.0M -31.2M
Tax provision 527.5K 1.1M 945.1K 596.6K
Net income -90.7M -177.7M -115.9M -31.8M
Basic EPS -1.2 -2.4 -1.6 -0.4
Diluted EPS -1.2 -2.4 -1.6 -0.4
Basic average shares 77.8M 74.2M 73.2M 72.8M
Diluted average shares 77.8M 74.2M 73.2M 72.8M
EBITDA -108.8M -191.5M -122.5M -50.9M
Net income from continuing op. -90.7M -177.7M -115.9M -31.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 3 hours 39 minutes

04:20
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).